SBC insider buying and SEC filings, explained
SBC Medical Group Holdings Inc · CIK 1930313
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$20.1M
Planned sales (10b5-1)
$0
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Apr 28, 2026 | Sale | Yoshiyuki Aikawa (CEO and Director) sold 465,000 shares at $3.02 ($1.4M). Holdings down 1% to 78,839,460 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 29, 2026 |
| Apr 21, 2026 | Sale | Yoshiyuki Aikawa (CEO and Director) sold 3,100,000 shares at $3.02 ($9.4M). Holdings down 4% to 79,304,460 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Apr 23, 2026 |
| Mar 6, 2026 | Sale | Yoshiyuki Aikawa (CEO and Director) sold 4,422,900 shares indirectly at $2.12 ($9.4M). Indirect holdings down 84% to 861,600 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 10, 2026 |
1 routine transaction (such as a grant, option exercise or tax withholding) is not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow SBC in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.